A real life experience of omalizumab: Nine‐year follow‐up of 205 patients in a single center.

ÖZTOP N., GELİNCİK A., DEMİR S., BEYAZ Ş., tüzer c., yeğit o., ...More

European Academy of Allergy and Clinical Immunology Congress, 1 - 05 June 2019

  • Publication Type: Conference Paper / Full Text
  • Çanakkale Onsekiz Mart University Affiliated: No